Unlocking how to use mRNA to target Alzheimer’s disease

HMN 2024 – Graphical Abstract. Credit: Brain Communications (2024). DOI: 10.1093/braincomms/fcae100 Scientists at The Florey have developed an mRNA technology approach to target the toxic protein tau, which builds up in patients with Alzheimer’s disease and other dementias. To date, mRNA has been predominantly used for vaccines, including those used to fight COVID-19. New research published in Brain […]

 ……… Read More